What is Citizens Jmp’s Estimate for Teleflex Q1 Earnings?

Teleflex Incorporated (NYSE:TFX) – Research analysts at Citizens Jmp issued their Q1 2025 earnings estimates for Teleflex in a research note issued to investors on Wednesday, April 2nd. Citizens Jmp analyst D. Turkaly forecasts that the medical technology company will earn $2.77 per share for the quarter. Citizens Jmp currently has a “Market Perform” rating on the stock. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Citizens Jmp also issued estimates for Teleflex’s Q2 2025 earnings at $3.45 EPS, Q3 2025 earnings at $3.70 EPS, Q4 2025 earnings at $4.18 EPS, FY2025 earnings at $14.10 EPS, Q1 2026 earnings at $3.47 EPS, Q2 2026 earnings at $3.80 EPS, Q3 2026 earnings at $3.88 EPS, Q4 2026 earnings at $4.10 EPS and FY2026 earnings at $15.25 EPS.

Several other equities analysts have also recently weighed in on TFX. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. Morgan Stanley reduced their price objective on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a research note on Wednesday, March 5th. Finally, Wells Fargo & Company dropped their target price on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $182.63.

Teleflex Stock Down 4.4 %

NYSE:TFX opened at $131.93 on Monday. The stock has a 50-day simple moving average of $154.86 and a 200 day simple moving average of $186.26. Teleflex has a 52-week low of $128.55 and a 52-week high of $249.91. The company has a market cap of $6.12 billion, a PE ratio of 26.23, a PEG ratio of 1.73 and a beta of 1.19. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 1.03%. Teleflex’s dividend payout ratio is currently 95.77%.

Institutional Investors Weigh In On Teleflex

Hedge funds have recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB grew its position in shares of Teleflex by 103.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company’s stock worth $27,000 after purchasing an additional 100 shares in the last quarter. Headlands Technologies LLC acquired a new position in shares of Teleflex during the fourth quarter worth $29,000. True Wealth Design LLC raised its position in Teleflex by 62.3% in the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company’s stock valued at $48,000 after purchasing an additional 104 shares during the last quarter. Avior Wealth Management LLC boosted its stake in shares of Teleflex by 81.2% during the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company’s stock valued at $50,000 after purchasing an additional 125 shares in the last quarter. Finally, IFP Advisors Inc raised its holdings in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after buying an additional 217 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.